scispace - formally typeset
P

Philippe Bachellier

Researcher at University of Strasbourg

Publications -  297
Citations -  12645

Philippe Bachellier is an academic researcher from University of Strasbourg. The author has contributed to research in topics: Hepatectomy & Liver transplantation. The author has an hindex of 52, co-authored 267 publications receiving 10978 citations. Previous affiliations of Philippe Bachellier include Aix-Marseille University & University of Franche-Comté.

Papers
More filters
Journal ArticleDOI

Upfront versus resection after neoadjuvant chemotherapy for pancreatic adenocarcinomas with venous contact: comparative analysis of operative and survival outcomes.

TL;DR: In this article , the outcomes of upfront and resection after neoadjuvant chemotherapy (NAC) for pancreatic adenocarcinoma were compared, and the effect of perioperative transfusion on overall survival was investigated.
Journal ArticleDOI

Predicting the available space for liver transplantation in cirrhotic patients: a computed tomography-based volumetric study

TL;DR: In this article, the authors evaluated the clinical factors influencing the overall available space for implanting a liver graft in cirrhotic patients undergoing liver transplantation and found that the Hashimoto formula (961.3 × BSA_D-404.8) yielded the lowest median absolute percentage error (21.7%) in predicting the liver volume.
Journal ArticleDOI

Limited role of carbidopa-assisted 18F-FDOPA PET/CT in patients with sporadic non-functional gastroduodenal neuroendocrine neoplasms

TL;DR: 18F-FDOPA PET/CT is not sufficiently accurate for localization of primary well-differentiated nonfunctioning sporadic gastroduodenal NENs and its value for the assessment of visceral and lymph node metastases needs to be clarified in multicenter trials including a larger number of patients.
Journal ArticleDOI

Impact of biomarkers expression before and after portal vein embolization on recurrence after two-stage hepatectomy for colorectal liver metastases.

TL;DR: Bcl-2 ratio was an independent prognostic factor for recurrence-free survival and may predict early recurrence and identify patients who do not require postoperative chemotherapy in patients undergoing TSH with PVE for CLM.